AVEO is a late-stage biopharmaceutical company focused on the discovery and development of targeted cancer therapeutics. AVEO's proprietary, integrated cancer biology platform enables the company to pursue highly efficient drug development strategies in oncology that increase the probability of clinical success and provides a discovery engine for high-value targets and therapies. This approach has resulted in a balanced pipeline of novel cancer therapies focused on well-validated targets (VEGFR, EGFR) and promising novel targets (HGF, FGFR, ErbB3 and NOTCH), as well as collaborations with Eli Lilly, Merck, OSI Pharmaceuticals, Schering-Plough, and Biogen Idec. The company was established in 2001 and is based in Cambridge, Massachusetts.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of AVEO Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AVEO Pharmaceuticals Inc market cap is $521.45M.
What is the 52-week high for AVEO Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AVEO Pharmaceuticals Inc 52 week high is $15.00 as of September 29, 2025.
What is the 52-week low for AVEO Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AVEO Pharmaceuticals Inc 52 week low is $3.06 as of September 29, 2025.
What is AVEO Pharmaceuticals Inc stock price today?
AVEO Pharmaceuticals Inc stock price today is $15.00.
What was AVEO Pharmaceuticals Inc stock price yesterday?
AVEO Pharmaceuticals Inc stock price yesterday was $15.00.
What is the PE ratio of AVEO Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. AVEO Pharmaceuticals Inc’s P/E ratio is -17.81.
What is the Price-to-Book ratio of AVEO Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AVEO Pharmaceuticals Inc P/B ratio is 18.0037.
What is the 50-day moving average of AVEO Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AVEO Pharmaceuticals Inc 50-day moving average is $14.90.
